HP-007

N/A

Report date: 2026/02/11 20:01:36
NME

Base Information

Drug NameHP-007
Drug Alias NameHP007HP-007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChangchun Huapu Bio-Tech CoJiangsu Taipuri Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChangchun Huapu Bio-Tech CoHuapu Shijiazhuang Pharmaceutical Co LtdJiangsu Taipuri Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A